IRIS
POLLICINO, Teresa
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 2.695
EU - Europa 2.431
AS - Asia 472
SA - Sud America 13
OC - Oceania 10
Continente sconosciuto - Info sul continente non disponibili 2
Totale 5.623
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 2.686
IE - Irlanda 775
SE - Svezia 684
CN - Cina 414
IT - Italia 291
UA - Ucraina 170
PL - Polonia 152
DE - Germania 128
FI - Finlandia 92
GB - Regno Unito 53
IN - India 33
BE - Belgio 30
FR - Francia 30
VN - Vietnam 17
BR - Brasile 11
RU - Federazione Russa 10
CA - Canada 9
NZ - Nuova Zelanda 8
ES - Italia 4
NL - Olanda 4
BD - Bangladesh 3
IR - Iran 3
AT - Austria 2
AU - Australia 2
CL - Cile 2
EU - Europa 2
BG - Bulgaria 1
CH - Svizzera 1
HR - Croazia 1
LV - Lettonia 1
MY - Malesia 1
PT - Portogallo 1
RO - Romania 1
TR - Turchia 1
Totale 5.623
Salva come PNG Salva come JPEG
Città #
Dublin 775
Chandler 543
Nyköping 408
Jacksonville 371
Ashburn 326
Beijing 217
Messina 188
Warsaw 146
Princeton 119
Ann Arbor 117
Medford 98
Cambridge 90
Des Moines 82
Boardman 61
Dearborn 51
Jinan 39
Houston 37
Wilmington 36
Woodbridge 36
Brussels 30
Pune 27
San Mateo 27
Falls Church 21
Nanjing 21
Dong Ket 16
New York 16
Shenyang 15
Zhengzhou 15
Rosolini 14
Hebei 13
Brasília 11
Norwalk 11
Los Angeles 10
Tianjin 10
Haikou 9
Guangzhou 8
Seattle 8
Tappahannock 8
Ottawa 7
Fuzhou 6
Hangzhou 6
Nanchang 6
Ningbo 6
Taizhou 6
Whakatane 6
Catania 5
Changsha 5
Lanzhou 5
Rome 5
Washington 5
Auburn Hills 4
Avola 4
Bremen 4
Helsinki 4
Qingdao 4
Radomsko 4
Taiyuan 4
Ardabil 3
Hyderabad 3
Pachino 3
Reggio Calabria 3
Saint Petersburg 3
San Giovanni la Punta 3
Belpasso 2
Bogra 2
Catanzaro 2
Culver City 2
Edinburgh 2
Jiaxing 2
Kraków 2
Lappeenranta 2
Leawood 2
Madrid 2
Manchester 2
Manerba del Garda 2
Monmouth Junction 2
Nuremberg 2
Piazza Armerina 2
Verona 2
Vienna 2
Villejuif 2
Vittoria 2
Wellington 2
Afyonkarahisar 1
Augusta 1
Baotou 1
Barcelona 1
Berlin 1
Boston 1
Caserta 1
Chengdu 1
Chicago 1
Clearwater 1
Clute 1
Delhi 1
Fairfield 1
Great Yarmouth 1
Guiyang 1
Hanoi 1
Hanover 1
Totale 4.201
Salva come PNG Salva come JPEG
Nome #
Impact of hepatitis B virus (HBV) preS/S genomic variability on HBV surface antigen and HBV DNA serum levels. 268
PIVKA-II is a useful tool for diagnostic characterization of ultrasound-detected liver nodules in cirrhotic patients 127
Hepatitis B virus (HBV) DNA integration in patients with occult HBV infection and hepatocellular carcinoma. 125
Lack of the NS5B S282T mutation in HCV isolates from liver tissue of naive patients with HCV genotype-1b infection. 102
Free episomal and integrated HBV DNA In HBsAg-negative patients with intrahepatic cholangiocarcinoma 92
24th IFSO World Congress O-165 RISK FACTORS ASSOCIATED WITH NASH IN OBESE PATIENTS UNDERGOING BARIATRIC SURGERY 89
Analysis of haemochromatosis gene mutations in a population from the Mediterranean Basin. 86
Evaluation of CTNNB1 and TP53 variability in patients with hepatocellular carcinoma and occult hepatitis B virus infection 85
The characteristics of the cell-mediated immune response identify different profiles of occult hepatitis B virus infection. 83
Non-sequencing molecular approaches to identify preS2-defective hepatitis B virus variants proved to be associated with severe liver diseases 81
Is there a downgrading in the alert about the hepatitis B virus infection in Italy? 79
NS3 Variability in Hepatitis C Virus Genotype 1A Isolates from Liver Tissue and Serum Samples of Treatment-Naïve Patients with Chronic Hepatitis C 78
Update of the statements on biology and clinical impact of occult hepatitis B virus infection 75
Obesity and liver cancer 73
Is investigation of hepatitis C virus NS5A gene heterogeneity a tool for predicting long-lasting response to interferon therapy in patients with HCV-1b chronic hepatitis? 72
FULMINANT-HEPATITIS ASSOCIATED WITH THE INTRAFAMILIAR SPREAD OF A PRE-S2 DEFECTIVE HBV VARIANT AND THE LATE EMERGENCE OF HBEAG- MINUS VIRAL STRAINS 62
A 2010 update on occult hepatitis B infection. 61
Analysis of occult hepatitis B virus infection in liver tissue of HIV patients with chronic hepatitis C. 60
TT virus has a ubiquitous diffusion in human body tissues: analyses of paired serum and tissue samples. 59
Both interferon alpha and lambda can reduce all intrahepatic HDV infection markers in HBV/HDV infected humanized mice 59
Occult hepatitis B virus infection is associated with the development of hepatocellular carcinoma in chronic hepatitis C patients. 59
Clinical virology of hepatitis B virus infection 58
Occult hepatitis B virus in liver tissue of individuals without hepatic disease. 58
Hepatitis B virus maintains its pro-oncogenic properties in the case of occult HBV infection 58
HEPATITIS B VIRUS INDUCES INTERLEUKIN-8 (IL8) PRODUCTION IN HEPATOCYTES AND IL-8 IN TURN INHIBITS INTERFERON ALFA ANTIVIRAL ACTIVITY 58
HEPATITIS B VIRUS INDUCES INTERLEUKIN-8 N(IL-8) PRODUCTION IN HEPATOCYTES AND IL-8 IN TURN INHIBITS INERFERON ALFA ANTIVIRAL ACITIVITY 58
[A glance into the past ... Southern and northern blot: really superseded?] 58
Cirrhosis related to wild-type HBV infection in siblings with A3 - B35 - Cw4 HLA class I phenotype. 58
Replicative and transcriptional activities of hepatitis B virus in patients coinfected with hepatitis B and hepatitis delta viruses. 58
Variability of reverse transcriptase and overlapping S gene in hepatitis B virus isolates from untreated and lamivudine-resistant chronic hepatitis B patients. 57
Infection with HBV preS/S Variants is Highly Prevalent and Influences Amount of Circulating HBsAg Independently of Serum HBV DNA Levels and Response to Interferon Therapy in Chronic Hepatitis B 57
Frequency of somatic mutations in TERT promoter, TP53 and CTNNB1 genes in patients with hepatocellular carcinoma from Southern Italy 57
INTRAHEPATIC HDV RNA, HBV DNA, AND HBV RNAS QUANTIFICATIONS REVEAL SUPPRESSION OF HBV PREGENOME RNA PRODUCTION WITH MAINTENANCE OF PRES/S TRNSCRITION IN HDV/HBV CO-INFECTED PATIENTS 56
Hepatitis E virus infection as a cause of acute hepatitis in Southern Italy 56
Neoangiogenesis-related genes are hallmarks of fast-growing hepatocellular carcinomas and worst survival. Results from a prospective study 56
Severe outcome of hepatitis B virus (HBV) infection and lack of HBV e antigen-defective virus emergence in patients homozygous for HLA class I alleles. 55
Control of cccDNA function in hepatitis B virus infection. 55
Flavocoxid exerts a potent antiviral effect against hepatitis B virus. 55
Role of humoral immunity against hepatitis B virus core antigen in the pathogenesis of acute liver failure 55
Evaluation of hepatitis B and C virus infections in patients with non-Hodgkin's lymphoma and without liver disease 54
Conserved transactivating and pro-apoptotic functions of hepadnaviral X protein in ortho- and avihepadnaviruses. 54
Proliferation of primary human hepatocytes and prevention of hepatitis B virus reinfection efficiently deplete nuclear cccDNA in vivo 54
Occult hepatitis B virus infection predicts non-alcoholic steatohepatitis in severely obese individuals from Italy 54
Risk of occult hepatitis B virus infection reactivation in patients with solid tumours undergoing chemotherapy 53
Hepatitis B e antigen detection in formalin-fixed liver biopsy specimens. A tool to investigate wild-type and E-minus variant HBV infection. 52
High prevalence of non-organ-specific autoantibodies in hepatitis C virus-infected cirrhotic patients from southern Italy. 52
NS3 Q80K Polymorphism in viral isolates from Liver Tissues and serum samples of naive HCV genotype 1a Patients 52
Behaviour of occult HBV infection in HCV-infected patients under treatment with direct-acting antivirals 52
Hepatitis B Virus Replication Is Regulated by the Acetylation Status of Hepatitis B Virus cccDNA-Bound H3 and H4 Histones 51
Hepatitis B virus (HBV) induces the expression of interleukin-8 that in turn reduces HBV sensitivity to interferon-alpha. 51
Prevalence of hepatitis B and C viral infections in hospitalized patients with increased liver enzyme levels and with no known history of hepatic disease 51
Hepatitis B Virus Causes Epigenetic Induction of Interleukin-8Production which in Turn Inhibits Interferon-alfa Antiviral Activity 50
Divergent effects of interleukin-10 on cytokine production by mononuclear phagocytes and endothelial cells. 49
Molecular and functional analysis of occult hepatitis B virus isolates from patients with hepatocellular carcinoma. 48
Molecular analyses of TT virus in paired and tissue samples from 150 patients with either hepatic or non-hepatic disease 48
Pre-S2 defective hepatitis B virus infection in patients with fulminant hepatitis. 48
Outcome of liver disease and response to interferon treatment are not influenced by hepatitis B virus core gene variability in children with chronic type B hepatitis. 48
Impact of Occult Hepatitis B Virus Infection on the Outcome of Chronic Hepatitis C. 48
Virological profiles in patients with chronic hepatitis C and overt or occult HBV infection. 46
Pro-apoptotic effect of the hepatitis B virus X gene. 46
Hepatitis B virus PreS/S gene variants: Pathobiology and clinical implications. 46
AISF position paper on liver transplantation and pregnancy: Women in Hepatology Group, Italian Association for the Study of the Liver (AISF) 46
The hepatitis B virus X protein abrogates Bcl-2-mediated protection against Fas apoptosis in the liver. 45
PRE-S GENETIC VARIANTS ARE HIGHLY PREVALENT AND SIGNIFICANTLY CORRELATE WITH LOWER LEVELS OF HBSAG IN ACTIVE HBV INFECTIONS 45
Disease progression and liver cancer in the ferroportin disease. 45
Occult hepatitis B virus infection in patients with chronic hepatitis C liver disease 45
HEPATITIS B VIRUS INDUCES INTERLEUKIN-8 PRODUCTION WHICH IN TURN INHIBITS INTERFERON ALFA ANTIVIRAL ACTIVITY IN HEPATOMA CELL LINES 44
Targeting Hepatitis B virus infected cells with a T-cell receptor like antibody 44
Transcriptional regulation of miR-224 upregulated in human HCCs by NFκB inflammatory pathways. 44
High prevalence of preS2-defective hepatitis B virus (HBV) infection in patients with type b fulminant hepatitis. 43
Virological profiles in hepatitis B virus inactive carriers: monthly evaluation in 1-year follow-up study 42
Genomic heterogeneity of hepatitis B virus (HBV) and outcome of perinatal HBV infection. 42
NS3 genetic variability in hepatitis C virus genotype-1b isolates from liver specimens and blood samples of treatment naïve patients with chronic hepatitis C 42
Statements from the Taormina expert meeting on occult hepatitis B virus infection. 41
Occult hepatitis B virus and hepatocellular carcinoma. 41
Human hepatitis B virus negatively impacts the protective immune cross-talk between natural killer and dendritic cells 41
Heterogeneity of HBV genome. 40
Resistance analysis and treatment outcomes in hepatitis C virus genotype 3 infected patients within the Italian network VIRONET-C 40
Hepatitis B virus DNA integration in tumour tissue of a non-cirrhotic HFE-haemochromatosis patient with hepatocellular carcinoma. 39
Occult HBV infection 39
Infection with hepatitis C virus depends on TACSTD2, a regulator of claudin-1 and occludin highly downregulated in hepatocellular carcinoma 39
What is the clinical impact of occult hepatitis B virus infection? 38
Occult hepatitis B virus infection 37
Occult hepatitis B virus infection 37
Type II interleukin-1 receptor is not expressed in cultured endothelial cells and is not involved in endothelial cell activation. 37
Frequent NS5A and multiclass resistance in almost all HCV genotypes at DAA failures: What are the chances for second-line regimens? 37
Nuclear HBx binds the HBV minichromosome and modifies the epigenetic regulation of cccDNA function. 36
Quantification of intrahepatic hepatitis B virus (HBV) DNA in patients with chronic HBV infection. 36
Regulated expression of vascular cell adhesion molecule-1 in human malignant melanoma. 34
Treatment of chronic hepatitis B: update of the recommendations from the 2007 Italian Workshop 34
Hepatocellular carcinoma: the point of view of the hepatitis B virus. 34
Hepatitis B viral replication influences the expression of natural killer cell ligands 34
PreS and core gene heterogeneity in hepatitis B virus (HBV) genomes isolated from patients with long-lasting HBV chronic infection. 33
Occult hepatitis B virus infection in hepatitis C virus negative chronic liver diseases 33
Ficolin-2 Plasma Level Assesses Liver Fibrosis in Non-Alcoholic Fatty Liver Disease 33
Hepatitis B virus basal core promoter mutations show lower replication fitness associated with cccDNA acetylation status 32
null 31
Co-circulation of SARS-CoV-2 Alpha and Gamma variants in Italy, February and March 2021 31
Integration of hepatitis B virus DNA in chronically infected patients assessed by Alu-PCR. 30
Practice guidelines for the treatment of hepatitis C: recommendations from an AISF/SIMIT/SIMAST Expert Opinion Meeting. 28
Totale 5.497
Salva come PNG Salva come JPEG
Categoria #
all - tutte 20.881
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 20.881
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2018/20199 0 0 0 0 0 0 0 0 0 0 2 7
2019/2020800 89 45 12 25 7 57 93 84 27 156 174 31
2020/2021833 77 18 154 50 68 83 39 96 44 103 51 50
2021/2022745 7 57 27 30 57 16 63 33 18 99 99 239
2022/20232.196 164 250 104 176 138 224 45 100 906 14 61 14
2023/2024654 50 111 26 61 41 103 2 228 3 23 6 0
Totale 5.791